Global X Defense Tech ETF vs Twist Bioscience Corp — how do they compare? Global X Defense Tech ETF trades at $60.14, while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Twist Bioscience Corp is trading nearer its 52-week high, Global X Defense Tech ETF nearer its low. Which is the better fit depends on your goals.
| SHLD | TWST | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $78.02 | $102.88 |
52-Week Low | $58.20 | $24.16 |
Market Cap | — | $5.45B |
Enterprise Value | — | $5.37B |
Signals from Pluang's Aura AI — not financial advice
SHLD trades at $60.03, down slightly by 0.05% with a bearish technical signal from moving averages. The ETF offers exposure to global defense technology companies amid rising military spending trends. Recent news highlights institutional buying interest and geopolitical tailwinds supporting the sector's growth outlook.
The defense technology theme benefits from increased global budgets, but SHLD faces competition from other defense ETFs and valuation concerns. Near-term technical support at $59 could stabilize declines, while resistance at $61 may cap upside. Risks include political shifts and execution challenges among holdings.
TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.
The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.
Trailing returns across standard periods
Latest headlines on both assets
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →